查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1236107

鼻咽癌全球市場規模研究和預測，按治療（化療、免疫療法、放療等），按最終用戶（醫院/診所、門診手術中心、其他最終用戶），區域分析，2022 -2029

Global Nasopharyngeal Cancer Market Size study & Forecast, by Therapy (Chemotherapy, Immunotherapy, Radiation Therapy, and Others), by End-User (Hospitals and Clinics, Ambulatory Surgery Centers, and Other End-Users), and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

鼻咽癌是頭頸癌之一，感染風險高於其他患者。

這是一種在鼻咽組織中形成惡性癌細胞的疾病。 鼻咽癌市場在癌症發病率上升、診療意識提高等因素的推動下不斷擴大。

根據國際世界癌症研究基金會 (WCRF) 更新至 2022 年的數據，鼻咽癌是全球最常見的癌症，在女性癌症中排名第 22 位，在男性癌症中排名第 18 位。 據 WCRF 稱，到 2020 年，全球將診斷出約 133,000 例鼻咽癌新病例。 另一方面，增加政府在公共衛生保健方面的支出、增加臨床試驗和癌症研究活動正在市場上創造有利可圖的機會。 然而，不斷上升的治療成本將阻礙整個 2022-2029 年預測期內的市場增長。

全球鼻咽癌市場研究考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於研發支出增加和與臨床試驗相關的產品批准增加，亞太地區在收入方面佔據市場主導地位。 由於鼻咽癌患病率上升和預測期內市場參與者的戰略舉措等因素，預計亞太地區在預測期內將以最高複合年增長率增長。

近期市場趨勢

  • 2022 年 2 月，在印度加爾各答，KMC 診所開始在頭頸科進行癌症篩查，包括鼻咽癌。 該篩查計劃是與印度醫學協會 (IMA)、印度牙科協會 (IDA) 和 Medica 超級專科醫院合作開發的。 它將在 KMC 的所有 16 個中心實施。
  • 2022 年 1 月，Wistar 研究所宣布了口服抑製劑 VK-2019 在晚期 EB 病毒陽性鼻咽癌和淋巴瘤（一種罕見的頭頸癌）患者中的安全性。一項旨在調查的 2 期研究療效和有效性已經啟動。 斯坦福大學醫學院的研究人員正在領導這項研究。

全球鼻咽癌市場報告範圍

  • 歷史數據：2019-2020-2021
  • 估算基準年：2021 年
  • 預測期：2022-2029
  • 報告範圍：收入預測、公司排名、競爭格局、增長因素、趨勢
  • 按地區劃分：北美、歐洲、亞太地區、拉丁美洲、世界其他地區
  • 定制範圍：免費報告定制（最多 8 個工作小時）。 按國家、地區和部門劃分的範圍的添加和更改。

本研究的目的是弄清近年來各個領域和國家的市場規模，並對未來幾年的市場規模進行預測。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還結合了利益相關者投資的潛在微觀市場機會，以及主要參與者的競爭格局等詳細分析。

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年各細分市場的全球市場估計和預測
    • 2019-2029 年按地區劃分的鼻咽癌市場
    • 2019-2029 年按治療分類的鼻咽癌市場
    • 鼻咽癌市場，按最終用戶分類，2019-2029 年
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章鼻咽癌全球市場定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 本次調查涵蓋的年份
  • 貨幣兌換率

第三章鼻咽癌全球市場動態

  • 鼻咽癌市場影響分析（2019-2029）
    • 市場驅動因素
      • 癌症患病率上升
      • 提高診斷和治療意識
    • 市場挑戰
      • 治療費用高
    • 市場機會
      • 增加政府在公共醫療保健方面的支出
      • 臨床試驗和癌症研究活動的增長

第 4 章鼻咽癌全球市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 最佳投資機會
  • 關鍵成功策略
  • 業內人士的前景
  • 分析師的建議和結論

第 5 章風險評估 COVID-19 影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球鼻咽癌市場：按治療分類

  • 市場概況
  • 全球鼻咽癌市場：按治療、按表現 - 潛力分析
  • 2019-2029 年按治療方法分類的鼻咽癌全球市場估計和預測
  • 鼻咽癌市場，按細分市場分析
    • 化療
    • 免疫療法
    • 放射治療
    • 其他

第 7 章全球鼻咽癌市場：按最終用戶分類

  • 市場概況
  • 全球鼻咽癌市場：按最終用戶分類），性能潛力分析
  • 2019-2029 年最終用戶對鼻咽癌全球市場的估計和預測
  • 鼻咽癌市場，按細分市場分析
    • 醫院和診所
    • 門診手術中心
    • 其他最終用戶

第 8 章全球鼻咽癌市場：區域分析

  • 鼻咽癌市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 按療法估算和預測，2019-2029 年
      • 2019-2029 年最終用戶的估計和預測
    • 加拿大
  • 歐洲鼻咽癌市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 亞太地區鼻咽癌市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲鼻咽癌市場概況
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 世界其他地區

第 9 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • 百康有限公司
      • 關鍵信息
      • 概覽
      • 財務（僅當數據可用時）
      • 產品概覽
      • 近期趨勢
    • Bristol Myers Squibb Company
    • Cyclacel Pharmaceuticals
    • F. Hoffman La-Roche Ltd
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer, Inc.
    • GSK plc.
    • Sanofi
    • Theravectys SA

第 10 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查的特點
  • 調查先決條件

The global Nasopharyngeal Cancer Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Nasopharyngeal Cancer is a head and neck cancer that possesses a risk of infection than other patients. It is a disease in which malignant cancer cells are formed in the tissues of the nasopharynx. The Nasopharyngeal Cancer market is expanding because of factors such as the rising prevalence of cancer diseases and increasing awareness towards diagnosis and treatment.

According to World Cancer Research Fund International (WCRF) data updated in 2022, NPC is the 22nd most common cancer in the world, ranking 22nd among cancers in women and 18th among cancers in men. According to the WCRF, approximately 133,000 new NPC cases will be diagnosed globally in 2020. Whereas rising government spending on public healthcare and growing clinical trials & cancer research activities create lucrative opportunities for the market. However, higher treatment costs hamper the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Nasopharyngeal Cancer Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Asia Pacific dominated the market in terms of revenue, owing to the increasing research and development expenditure, and growing product approvals associated with clinical trials. Whereas the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increasing prevalence of nasopharyngeal cancer and strategic initiatives by market players in the forecast period

Major market players included in this report are:

  • Biocon Limited
  • Bristol Myers Squibb Company
  • Cyclacel Pharmaceuticals
  • F. Hoffman La-Roche Ltd
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • GSK plc.
  • Sanofi
  • Theravectys SA

Recent Developments in the Market:

  • In February 2022, In Kolkata, India, KMC clinics began cancer screening, including nasopharyngeal cancer under the head and neck division. The screening program was developed in partnership with the Indian Medical Association (IMA), the Indian Dental Association (IDA), and Medica Super specialty Hospital. It is expected to be carried out at all 16 KMC centers
  • In January 2022, The Wistar Institute initiated a phase 2 trial to investigate the safety and efficacy of the oral inhibitor VK-2019 in patients with advanced Epstein-Barr Virus-positive nasopharyngeal carcinoma, a rare type of head and neck cancer, and lymphoma. Stanford University School of Medicine researchers are leading the trial.

Global Nasopharyngeal Cancer Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Therapy, End-user, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapy:

  • Chemotherapy
  • Immunotherapy
  • Radiation Therapy
  • Others

By End-user:

  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Other End-users

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Nasopharyngeal Cancer Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Nasopharyngeal Cancer Market, by Therapy, 2019-2029 (USD Billion)
    • 1.2.3. Nasopharyngeal Cancer Market, by End-User, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Nasopharyngeal Cancer Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Nasopharyngeal Cancer Market Dynamics

  • 3.1. Nasopharyngeal Cancer Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising prevalence of cancer diseases
      • 3.1.1.2. Increasing awareness toward diagnosis and treatment
    • 3.1.2. Market Challenges
      • 3.1.2.1. Higher treatment cost
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising government spending toward public healthcare
      • 3.1.3.2. Growing clinical trials and cancer research activities

Chapter 4. Global Nasopharyngeal Cancer Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Nasopharyngeal Cancer Market, by Therapy

  • 6.1. Market Snapshot
  • 6.2. Global Nasopharyngeal Cancer Market by Therapy, Performance - Potential Analysis
  • 6.3. Global Nasopharyngeal Cancer Market Estimates & Forecasts by Therapy 2019-2029 (USD Billion)
  • 6.4. Nasopharyngeal Cancer Market, Sub-Segment Analysis
    • 6.4.1. Chemotherapy
    • 6.4.2. Immunotherapy
    • 6.4.3. Radiation Therapy
    • 6.4.4. Others

Chapter 7. Global Nasopharyngeal Cancer Market, by End-User

  • 7.1. Market Snapshot
  • 7.2. Global Nasopharyngeal Cancer Market by End-User, Performance - Potential Analysis
  • 7.3. Global Nasopharyngeal Cancer Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
  • 7.4. Nasopharyngeal Cancer Market, Sub-Segment Analysis
    • 7.4.1. Hospitals and Clinics
    • 7.4.2. Ambulatory Surgery Centers
    • 7.4.3. Other End-users

Chapter 8. Global Nasopharyngeal Cancer Market, Regional Analysis

  • 8.1. Nasopharyngeal Cancer Market, Regional Market Snapshot
  • 8.2. North America Nasopharyngeal Cancer Market
    • 8.2.1. U.S. Nasopharyngeal Cancer Market
      • 8.2.1.1. Therapy breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. End-User breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Nasopharyngeal Cancer Market
  • 8.3. Europe Nasopharyngeal Cancer Market Snapshot
    • 8.3.1. U.K. Nasopharyngeal Cancer Market
    • 8.3.2. Germany Nasopharyngeal Cancer Market
    • 8.3.3. France Nasopharyngeal Cancer Market
    • 8.3.4. Spain Nasopharyngeal Cancer Market
    • 8.3.5. Italy Nasopharyngeal Cancer Market
    • 8.3.6. Rest of Europe Nasopharyngeal Cancer Market
  • 8.4. Asia-Pacific Nasopharyngeal Cancer Market Snapshot
    • 8.4.1. China Nasopharyngeal Cancer Market
    • 8.4.2. India Nasopharyngeal Cancer Market
    • 8.4.3. Japan Nasopharyngeal Cancer Market
    • 8.4.4. Australia Nasopharyngeal Cancer Market
    • 8.4.5. South Korea Nasopharyngeal Cancer Market
    • 8.4.6. Rest of Asia Pacific Nasopharyngeal Cancer Market
  • 8.5. Latin America Nasopharyngeal Cancer Market Snapshot
    • 8.5.1. Brazil Nasopharyngeal Cancer Market
    • 8.5.2. Mexico Nasopharyngeal Cancer Market
    • 8.5.3. Rest of Latin America Nasopharyngeal Cancer Market
  • 8.6. Rest of The World Nasopharyngeal Cancer Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Biocon Limited
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Bristol Myers Squibb Company
    • 9.2.3. Cyclacel Pharmaceuticals
    • 9.2.4. F. Hoffman La-Roche Ltd
    • 9.2.5. Merck & Co., Inc.
    • 9.2.6. Novartis AG
    • 9.2.7. Pfizer, Inc.
    • 9.2.8. GSK plc.
    • 9.2.9. Sanofi
    • 9.2.10. Theravectys SA

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Nasopharyngeal Cancer Market, report scope
  • TABLE 2. Global Nasopharyngeal Cancer Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Nasopharyngeal Cancer Market estimates & forecasts by Therapy 2019-2029 (USD Billion)
  • TABLE 4. Global Nasopharyngeal Cancer Market estimates & forecasts by End-User 2019-2029 (USD Billion)
  • TABLE 5. Global Nasopharyngeal Cancer Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Nasopharyngeal Cancer Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Nasopharyngeal Cancer Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Nasopharyngeal Cancer Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Nasopharyngeal Cancer Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Nasopharyngeal Cancer Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Nasopharyngeal Cancer Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Nasopharyngeal Cancer Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Nasopharyngeal Cancer Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Nasopharyngeal Cancer Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Nasopharyngeal Cancer Market
  • TABLE 70. List of primary sources, used in the study of global Nasopharyngeal Cancer Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Nasopharyngeal Cancer Market, research methodology
  • FIG 2. Global Nasopharyngeal Cancer Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Nasopharyngeal Cancer Market, key trends 2021
  • FIG 5. Global Nasopharyngeal Cancer Market, growth prospects 2022-2029
  • FIG 6. Global Nasopharyngeal Cancer Market, porters 5 force model
  • FIG 7. Global Nasopharyngeal Cancer Market, pest analysis
  • FIG 8. Global Nasopharyngeal Cancer Market, value chain analysis
  • FIG 9. Global Nasopharyngeal Cancer Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Nasopharyngeal Cancer Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Nasopharyngeal Cancer Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Nasopharyngeal Cancer Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Nasopharyngeal Cancer Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Nasopharyngeal Cancer Market, regional snapshot 2019 & 2029
  • FIG 15. North America Nasopharyngeal Cancer Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Nasopharyngeal Cancer Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Nasopharyngeal Cancer Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Nasopharyngeal Cancer Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Nasopharyngeal Cancer Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable